COVID-19 updates, including vaccine information, for our patients and visitors, Learn More
About John W. Adamson, MD
John Adamson, MD is a board-certified hematologist with a special focus in red blood cell, iron metabolism and platelet disorders.
A core member of the team at UC San Diego Health's Hemophilia and Thrombosis Treatment Center, he helps provide specialized care for people with bleeding and clotting disorders. Dr. Adamson has been involved in several clinical studies and has published more than 200 scientific and clinical papers. He has a particular interest in iron metabolism that occurs with acute and chronic inflammation, and in the use of supplemental iron to enhance the marrow's response to erythropoietin therapy. Erythropoietin is a hormone secreted by the kidneys that increases production of red blood cells.
Dr. Adamson helped organize the first clinical trials investigating recombinant human erythropoietin to treat anemia in people with chronic kidney disease, and the use of erythropoietin for chemotherapy-induced anemia in people with cancer.
In 2011 he participated in an international effort to standardize anemia management in CKD patients. He also served on the National Kidney Foundation's Dialysis Outcomes Quality Initiative group that developed best practices in the use of erythropoietin.
Prior to joining UC San Diego Health, Dr. Adamson was professor and head of the Division of Hematology in the Department of Medicine at the Medical College of Wisconsin in Milwaukee. He is a past president of the American Society of Hematology.
Dr. Adamson received his medical degree from University of California, Los Angeles. He completed residency and fellowship training at University of Washington, School of Medicine in Seattle, Washington. Dr. Adamson is board certified in internal medicine.
UC San Diego Health Links
For more information, see Hemophilia and Thrombosis Treatment Center.
- UC Los Angeles, School of Medicine, Los Angeles, CA
- University of Washington School of Medicine, Seattle, WA
Date Joined Staff
- American Board of Internal Medicine
Conditions and Treatments
- Platelet Disorders
- White Cell Disorders
- Bleeding/Clotting Problems
- Myeloproliferative Disorders